Nasdaq

Proteostasis Therapeutics Appoints Dr. Badrul Chowdhury, Former FDA Director of Pulmonology, Allergy, and Rheumatology, to Board of Directors

BOSTON, May 13, 2019 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to ...
Harvard Medical School

Announcing Dr. Rumman Chowdhury as Berkman Klein Center Responsible AI Fellow

The Berkman Klein Center for Internet & Society at Harvard University is thrilled to announce that Dr. Rumman Chowdhury has joined its annual fellowship cohort. Dr. Chowdhury expands on an impressive ...
Observer

Dr. Rumman Chowdhury: Culturally Aware A.I. Starts With Local Realities

Dr. Rumman Chowdhury advocates for grounding artificial intelligence in local realities. Courtesy of Humaine Intelligence The belief that A.I. will replace people is fundamentally mistaken. A.I., at ...
Seeking Alpha

Lightwave Logic, Inc. Announces Appointment of Dr. Aref Chowdhury as Chief Technology Officer & Head of Strategy

ENGLEWOOD, COLORADO / ACCESS Newswire / January 12, 2026 / Lightwave Logic, Inc. (LWLG) (the "Company"), a technology platform company leveraging its proprietary electro-optic (EO) polymers to ...
FIU News

FIU leads collaborative diabetes study focused on underserved communities in Bangladesh

As a new doctor back in the early 2000s, Dr. Rajiv Chowdhury learned quickly that there weren’t enough medically qualified care providers in Bangladesh to meet the needs of the country’s large ...